LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Book ; Online ; Thesis: Fluoreszenz-in-situ-Hybridisierung (FISH) mit „Bacterial Artificial Chromosome“(BAC)-Sonden bei zwei Patienten mit „Disease-associated balanced chromosome rearrangement“

    Schwaab, Ira [Verfasser]

    2022  

    Author's details Ira Schwaab
    Keywords Medizin, Gesundheit ; Medicine, Health
    Subject code sg610
    Language German
    Publisher Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
    Publishing place Mainz
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  2. Article ; Online: Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder.

    Poot, Martin / Beyer, Vera / Schwaab, Ira / Damatova, Natalja / Van't Slot, Ruben / Prothero, Jo / Holder, Sue E / Haaf, Thomas

    Neurogenetics

    2009  Volume 11, Issue 1, Page(s) 81–89

    Abstract: Patients with autism spectrum disorder (ASD) frequently harbour chromosome rearrangements and segmental aneuploidies, which allow us to identify candidate genes. In a boy with mild facial dysmorphisms, speech delay and ASD, we reconstructed by ... ...

    Abstract Patients with autism spectrum disorder (ASD) frequently harbour chromosome rearrangements and segmental aneuploidies, which allow us to identify candidate genes. In a boy with mild facial dysmorphisms, speech delay and ASD, we reconstructed by karyotyping, FISH and SNP array-based segmental aneuploidy profiling a highly complex chromosomal rearrangement involving at least three breaks in chromosome 1 and seven breaks in chromosome 7. Chromosome banding revealed an inversion of region 7q32.1-7q35 on the derivative chromosome 7. FISH with region-specific BACs mapped both inversion breakpoints and revealed additional breaks and structural changes in the CNTNAP2 gene. Two gene segments were transposed and inserted into the 1q31.2 region, while the CNTNAP2 segment between the two transposed parts as well as intron 13 to the 5-UTR were retained on the der(7). SNP array analysis revealed an additional de novo deletion encompassing the distal part of intron1 and exon 2 of CNTNAP2, which contains FOXP2 binding sites. Second, we found another de novo deletion on chromosome 1q41, containing 15 annotated genes, including KCTD3 and USH2A. Disruptions of the CNTNAP2 gene have been associated with ASD and with Gilles de la Tourette syndrome (GTS). Comparison of disruptions of CNTNAP2 in patients with GTS and ASD suggests that large proximal disruptions result in either GTS or ASD, while relatively small distal disruptions may be phenotypically neutral. For full-blown ASD to develop, a proximal disruption of CNTNAP2 may have to occur concomitantly with additional genome mutations such as hemizygous deletions of the KCTD3 and USH2A genes.
    MeSH term(s) 5' Untranslated Regions ; Aneuploidy ; Binding Sites ; Child Development Disorders, Pervasive/genetics ; Child, Preschool ; Humans ; In Situ Hybridization, Fluorescence ; Introns ; Karyotyping ; Language Development Disorders/genetics ; Male ; Membrane Proteins/genetics ; Mutation ; Nerve Tissue Proteins/genetics ; Polymorphism, Single Nucleotide ; Translocation, Genetic
    Chemical Substances 5' Untranslated Regions ; CNTNAP2 protein, human ; Membrane Proteins ; Nerve Tissue Proteins
    Language English
    Publishing date 2009-07-07
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1339887-8
    ISSN 1364-6753 ; 1364-6745
    ISSN (online) 1364-6753
    ISSN 1364-6745
    DOI 10.1007/s10048-009-0205-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.

    Fischer, Christine / Kuchenbäcker, Karoline / Engel, Christoph / Zachariae, Silke / Rhiem, Kerstin / Meindl, Alfons / Rahner, Nils / Dikow, Nicola / Plendl, Hansjörg / Debatin, Irmgard / Grimm, Tiemo / Gadzicki, Dorothea / Flöttmann, Ricarda / Horvath, Judit / Schröck, Evelin / Stock, Friedrich / Schäfer, Dieter / Schwaab, Ira / Kartsonaki, Christiana /
    Mavaddat, Nasim / Schlegelberger, Brigitte / Antoniou, Antonis C / Schmutzler, Rita

    Journal of medical genetics

    2013  Volume 50, Issue 6, Page(s) 360–367

    Abstract: Background: Risk prediction models are widely used in clinical genetic counselling. Despite their frequent use, the genetic risk models BOADICEA, BRCAPRO, IBIS and extended Claus model (eCLAUS), used to estimate BRCA1/2 mutation carrier probabilities, ... ...

    Abstract Background: Risk prediction models are widely used in clinical genetic counselling. Despite their frequent use, the genetic risk models BOADICEA, BRCAPRO, IBIS and extended Claus model (eCLAUS), used to estimate BRCA1/2 mutation carrier probabilities, have never been comparatively evaluated in a large sample from central Europe. Additionally, a novel version of BOADICEA that incorporates tumour pathology information has not yet been validated.
    Patients and methods: Using data from 7352 German families we estimated BRCA1/2 carrier probabilities under each model and compared their discrimination and calibration. The incremental value of using pathology information in BOADICEA was assessed in a subsample of 4928 pedigrees with available data on breast tumour molecular markers oestrogen receptor, progesterone receptor and human epidermal growth factor 2.
    Results: BRCAPRO (area under receiver operating characteristic curve (AUC)=0.80 (95% CI 0.78 to 0.81)) and BOADICEA (AUC=0.79 (0.78-0.80)), had significantly higher diagnostic accuracy than IBIS and eCLAUS (p<0.001). The AUC increased when pathology information was used in BOADICEA: AUC=0.81 (95% CI 0.80 to 0.83, p<0.001). At carrier thresholds of 10% and 15%, the net reclassification index was +3.9% and +5.4%, respectively, when pathology was included in the model. Overall, calibration was best for BOADICEA and worst for eCLAUS. With eCLAUS, twice as many mutation carriers were predicted than observed.
    Conclusions: Our results support the use of BRCAPRO and BOADICEA for decision making regarding genetic testing for BRCA1/2 mutations. However, model calibration has to be improved for this population. eCLAUS should not be used for estimating mutation carrier probabilities in clinical settings. Whenever possible, breast tumour molecular marker information should be taken into account.
    MeSH term(s) Adult ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Family ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Genetic Testing ; Germany/epidemiology ; Heterozygote ; Humans ; Male ; Middle Aged ; Models, Statistical ; Mutation ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/genetics ; Probability ; Risk Assessment ; Whites/genetics
    Chemical Substances BRCA1 Protein ; BRCA1 protein, human ; BRCA2 Protein ; BRCA2 protein, human
    Language English
    Publishing date 2013-04-06
    Publishing country England
    Document type Evaluation Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmedgenet-2012-101415
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.

    Johnatty, Sharon E / Beesley, Jonathan / Gao, Bo / Chen, Xiaoqing / Lu, Yi / Law, Matthew H / Henderson, Michelle J / Russell, Amanda J / Hedditch, Ellen L / Emmanuel, Catherine / Fereday, Sian / Webb, Penelope M / Goode, Ellen L / Vierkant, Robert A / Fridley, Brooke L / Cunningham, Julie M / Fasching, Peter A / Beckmann, Matthias W / Ekici, Arif B /
    Hogdall, Estrid / Kjaer, Susanne K / Jensen, Allan / Hogdall, Claus / Brown, Robert / Paul, Jim / Lambrechts, Sandrina / Despierre, Evelyn / Vergote, Ignace / Lester, Jenny / Karlan, Beth Y / Heitz, Florian / du Bois, Andreas / Harter, Philipp / Schwaab, Ira / Bean, Yukie / Pejovic, Tanja / Levine, Douglas A / Goodman, Marc T / Camey, Michael E / Thompson, Pamela J / Lurie, Galina / Shildkraut, Joellen / Berchuck, Andrew / Terry, Kathryn L / Cramer, Daniel W / Norris, Murray D / Haber, Michelle / MacGregor, Stuart / deFazio, Anna / Chenevix-Trench, Georgia

    Gynecologic oncology

    2013  Volume 131, Issue 1, Page(s) 8–14

    Abstract: Objective: ABCB1 encodes the multi-drug efflux pump P-glycoprotein (P-gp) and has been implicated in multi-drug resistance. We comprehensively evaluated this gene and flanking regions for an association with clinical outcome in epithelial ovarian cancer ...

    Abstract Objective: ABCB1 encodes the multi-drug efflux pump P-glycoprotein (P-gp) and has been implicated in multi-drug resistance. We comprehensively evaluated this gene and flanking regions for an association with clinical outcome in epithelial ovarian cancer (EOC).
    Methods: The best candidates from fine-mapping analysis of 21 ABCB1 SNPs tagging C1236T (rs1128503), G2677T/A (rs2032582), and C3435T (rs1045642) were analysed in 4616 European invasive EOC patients from thirteen Ovarian Cancer Association Consortium (OCAC) studies and The Cancer Genome Atlas (TCGA). Additionally we analysed 1,562 imputed SNPs around ABCB1 in patients receiving cytoreductive surgery and either 'standard' first-line paclitaxel-carboplatin chemotherapy (n=1158) or any first-line chemotherapy regimen (n=2867). We also evaluated ABCB1 expression in primary tumours from 143 EOC patients.
    Result: Fine-mapping revealed that rs1128503, rs2032582, and rs1045642 were the best candidates in optimally debulked patients. However, we observed no significant association between any SNP and either progression-free survival or overall survival in analysis of data from 14 studies. There was a marginal association between rs1128503 and overall survival in patients with nil residual disease (HR 0.88, 95% CI 0.77-1.01; p=0.07). In contrast, ABCB1 expression in the primary tumour may confer worse prognosis in patients with sub-optimally debulked tumours.
    Conclusion: Our study represents the largest analysis of ABCB1 SNPs and EOC progression and survival to date, but has not identified additional signals, or validated reported associations with progression-free survival for rs1128503, rs2032582, and rs1045642. However, we cannot rule out the possibility of a subtle effect of rs1128503, or other SNPs linked to it, on overall survival.
    MeSH term(s) ATP Binding Cassette Transporter, Subfamily B ; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/administration & dosage ; Carcinoma, Ovarian Epithelial ; Disease Progression ; Disease-Free Survival ; Drug Resistance, Multiple/genetics ; Drug Resistance, Neoplasm/genetics ; Female ; Humans ; Kaplan-Meier Estimate ; Neoplasms, Glandular and Epithelial/drug therapy ; Neoplasms, Glandular and Epithelial/genetics ; Neoplasms, Glandular and Epithelial/surgery ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/surgery ; Paclitaxel/administration & dosage ; Pharmacogenetics ; Polymorphism, Single Nucleotide ; Proportional Hazards Models
    Chemical Substances ABCB1 protein, human ; ATP Binding Cassette Transporter, Subfamily B ; ATP Binding Cassette Transporter, Subfamily B, Member 1 ; Carboplatin (BG3F62OND5) ; Paclitaxel (P88XT4IS4D)
    Language English
    Publishing date 2013-08-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 801461-9
    ISSN 1095-6859 ; 0090-8258
    ISSN (online) 1095-6859
    ISSN 0090-8258
    DOI 10.1016/j.ygyno.2013.07.107
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.

    Hedditch, Ellen L / Gao, Bo / Russell, Amanda J / Lu, Yi / Emmanuel, Catherine / Beesley, Jonathan / Johnatty, Sharon E / Chen, Xiaoqing / Harnett, Paul / George, Joshy / Williams, Rebekka T / Flemming, Claudia / Lambrechts, Diether / Despierre, Evelyn / Lambrechts, Sandrina / Vergote, Ignace / Karlan, Beth / Lester, Jenny / Orsulic, Sandra /
    Walsh, Christine / Fasching, Peter / Beckmann, Matthias W / Ekici, Arif B / Hein, Alexander / Matsuo, Keitaro / Hosono, Satoyo / Nakanishi, Toru / Yatabe, Yasushi / Pejovic, Tanja / Bean, Yukie / Heitz, Florian / Harter, Philipp / du Bois, Andreas / Schwaab, Ira / Hogdall, Estrid / Kjaer, Susan K / Jensen, Allan / Hogdall, Claus / Lundvall, Lene / Engelholm, Svend Aage / Brown, Bob / Flanagan, James / Metcalf, Michelle D / Siddiqui, Nadeem / Sellers, Thomas / Fridley, Brooke / Cunningham, Julie / Schildkraut, Joellen / Iversen, Ed / Weber, Rachel P / Berchuck, Andrew / Goode, Ellen / Bowtell, David D / Chenevix-Trench, Georgia / deFazio, Anna / Norris, Murray D / MacGregor, Stuart / Haber, Michelle / Henderson, Michelle J

    Journal of the National Cancer Institute

    2014  Volume 106, Issue 7

    Abstract: Background: ATP-binding cassette (ABC) transporters play various roles in cancer biology and drug resistance, but their association with outcomes in serous epithelial ovarian cancer (EOC) is unknown.: Methods: The relationship between clinical ... ...

    Abstract Background: ATP-binding cassette (ABC) transporters play various roles in cancer biology and drug resistance, but their association with outcomes in serous epithelial ovarian cancer (EOC) is unknown.
    Methods: The relationship between clinical outcomes and ABC transporter gene expression in two independent cohorts of high-grade serous EOC tumors was assessed with real-time quantitative polymerase chain reaction, analysis of expression microarray data, and immunohistochemistry. Associations between clinical outcomes and ABCA transporter gene single nucleotide polymorphisms were tested in a genome-wide association study. Impact of short interfering RNA-mediated gene suppression was determined by colony forming and migration assays. Association with survival was assessed with Kaplan-Meier analysis and log-rank tests. All statistical tests were two-sided.
    Results: Associations with outcome were observed with ABC transporters of the "A" subfamily, but not with multidrug transporters. High-level expression of ABCA1, ABCA6, ABCA8, and ABCA9 in primary tumors was statistically significantly associated with reduced survival in serous ovarian cancer patients. Low levels of ABCA5 and the C-allele of rs536009 were associated with shorter overall survival (hazard ratio for death = 1.50; 95% confidence interval [CI] =1.26 to 1.79; P = 6.5e-6). The combined expression pattern of ABCA1, ABCA5, and either ABCA8 or ABCA9 was associated with particularly poor outcome (mean overall survival in group with adverse ABCA1, ABCA5 and ABCA9 gene expression = 33.2 months, 95% CI = 26.4 to 40.1; vs 55.3 months in the group with favorable ABCA gene expression, 95% CI = 49.8 to 60.8; P = .001), independently of tumor stage or surgical debulking status. Suppression of cholesterol transporter ABCA1 inhibited ovarian cancer cell growth and migration in vitro, and statin treatment reduced ovarian cancer cell migration.
    Conclusions: Expression of ABCA transporters was associated with poor outcome in serous ovarian cancer, implicating lipid trafficking as a potentially important process in EOC.
    MeSH term(s) ATP Binding Cassette Transporter 1/genetics ; ATP Binding Cassette Transporter 1/metabolism ; ATP-Binding Cassette Transporters/genetics ; ATP-Binding Cassette Transporters/metabolism ; Carcinoma, Ovarian Epithelial ; Cell Movement ; Cystadenocarcinoma, Serous/genetics ; Cystadenocarcinoma, Serous/metabolism ; Cystadenocarcinoma, Serous/mortality ; Cystadenocarcinoma, Serous/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Genome-Wide Association Study ; Humans ; Kaplan-Meier Estimate ; Neoplasm Grading ; Neoplasms, Glandular and Epithelial/genetics ; Neoplasms, Glandular and Epithelial/metabolism ; Neoplasms, Glandular and Epithelial/mortality ; Neoplasms, Glandular and Epithelial/pathology ; Neoplastic Stem Cells ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; RNA, Messenger/metabolism ; Real-Time Polymerase Chain Reaction
    Chemical Substances ABCA1 protein, human ; ABCA5 protein, human ; ABCA6 protein, human ; ABCA8 protein, human ; ABCA9 protein, human ; ATP Binding Cassette Transporter 1 ; ATP-Binding Cassette Transporters ; RNA, Messenger
    Language English
    Publishing date 2014-06-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2992-0
    ISSN 1460-2105 ; 0027-8874 ; 0198-0157
    ISSN (online) 1460-2105
    ISSN 0027-8874 ; 0198-0157
    DOI 10.1093/jnci/dju149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

    Sucheston-Campbell, Lara E / Cannioto, Rikki / Clay, Alyssa I / Etter, John Lewis / Eng, Kevin H / Liu, Song / Battaglia, Sebastiano / Hu, Qiang / Szender, J Brian / Minlikeeva, Albina / Joseph, Janine M / Mayor, Paul / Abrams, Scott I / Segal, Brahm H / Wallace, Paul K / Soh, Kah Teong / Zsiros, Emese / Anton-Culver, Hoda / Bandera, Elisa V /
    Beckmann, Matthias W / Berchuck, Andrew / Bjorge, Line / Bruegl, Amanda / Campbell, Ian G / Campbell, Shawn Patrice / Chenevix-Trench, Georgia / Cramer, Daniel W / Dansonka-Mieszkowska, Agnieszka / Dao, Fanny / Diergaarde, Brenda / Doerk, Thilo / Doherty, Jennifer A / du Bois, Andreas / Eccles, Diana / Engelholm, Svend Aage / Fasching, Peter A / Gayther, Simon A / Gentry-Maharaj, Aleksandra / Glasspool, Rosalind M / Goodman, Marc T / Gronwald, Jacek / Harter, Philipp / Hein, Alexander / Heitz, Florian / Hillemmanns, Peter / Høgdall, Claus / Høgdall, Estrid V S / Huzarski, Tomasz / Jensen, Allan / Johnatty, Sharon E / Jung, Audrey / Karlan, Beth Y / Klapdor, Reudiger / Kluz, Tomasz / Konopka, Bożena / Kjær, Susanne Krüger / Kupryjanczyk, Jolanta / Lambrechts, Diether / Lester, Jenny / Lubiński, Jan / Levine, Douglas A / Lundvall, Lene / McGuire, Valerie / McNeish, Iain A / Menon, Usha / Modugno, Francesmary / Ness, Roberta B / Orsulic, Sandra / Paul, James / Pearce, Celeste Leigh / Pejovic, Tanja / Pharoah, Paul / Ramus, Susan J / Rothstein, Joseph / Rossing, Mary Anne / Rübner, Matthias / Schildkraut, Joellen M / Schmalfeldt, Barbara / Schwaab, Ira / Siddiqui, Nadeem / Sieh, Weiva / Sobiczewski, Piotr / Song, Honglin / Terry, Kathryn L / Van Nieuwenhuysen, Els / Vanderstichele, Adriaan / Vergote, Ignace / Walsh, Christine S / Webb, Penelope M / Wentzensen, Nicolas / Whittemore, Alice S / Wu, Anna H / Ziogas, Argyrios / Odunsi, Kunle / Chang-Claude, Jenny / Goode, Ellen L / Moysich, Kirsten B

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

    2016  Volume 26, Issue 3, Page(s) 420–424

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Carcinoma, Ovarian Epithelial ; Female ; Genetic Association Studies ; Genetic Variation ; Humans ; Myeloid-Derived Suppressor Cells/immunology ; Neoplasms, Glandular and Epithelial/genetics ; Neoplasms, Glandular and Epithelial/immunology ; Neoplasms, Glandular and Epithelial/mortality ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/mortality
    Language English
    Publishing date 2016-09-27
    Publishing country United States
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 1153420-5
    ISSN 1538-7755 ; 1055-9965
    ISSN (online) 1538-7755
    ISSN 1055-9965
    DOI 10.1158/1055-9965.EPI-16-0631
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

    French, Juliet D / Johnatty, Sharon E / Lu, Yi / Beesley, Jonathan / Gao, Bo / Kalimutho, Murugan / Henderson, Michelle J / Russell, Amanda J / Kar, Siddhartha / Chen, Xiaoqing / Hillman, Kristine M / Kaufmann, Susanne / Sivakumaran, Haran / O'Reilly, Martin / Wang, Chen / Korbie, Darren J / Lambrechts, Diether / Despierre, Evelyn / Van Nieuwenhuysen, Els /
    Lambrechts, Sandrina / Vergote, Ignace / Karlan, Beth / Lester, Jenny / Orsulic, Sandra / Walsh, Christine / Fasching, Peter A / Beckmann, Matthias W / Ekici, Arif B / Hein, Alexander / Matsuo, Keitaro / Hosono, Satoyo / Pisterer, Jacobus / Hillemanns, Peter / Nakanishi, Toru / Yatabe, Yasushi / Goodman, Marc T / Lurie, Galina / Matsuno, Rayna K / Thompson, Pamela J / Pejovic, Tanja / Bean, Yukie / Heitz, Florian / Harter, Philipp / du Bois, Andreas / Schwaab, Ira / Hogdall, Estrid / Kjaer, Susanne K / Jensen, Allan / Hogdall, Claus / Lundvall, Lene / Engelholm, Svend Aage / Brown, Bob / Flanagan, James M / Metcalf, Michelle D / Siddiqui, Nadeem / Sellers, Thomas / Fridley, Brooke / Cunningham, Julie / Schildkraut, Joellen M / Iversen, Ed / Weber, Rachel Palmieri / Brennan, Donal / Berchuck, Andrew / Pharoah, Paul / Harnett, Paul / Norris, Murray D / Haber, Michelle / Goode, Ellen L / Lee, Jason S / Khanna, Kum Kum / Meyer, Kerstin B / Chenevix-Trench, Georgia / deFazio, Anna / Edwards, Stacey L / MacGregor, Stuart

    Oncotarget

    2016  Volume 7, Issue 6, Page(s) 6353–6368

    Abstract: Women with epithelial ovarian cancer (EOC) are usually treated with platinum/taxane therapy after cytoreductive surgery but there is considerable inter-individual variation in response. To identify germline single-nucleotide polymorphisms (SNPs) that ... ...

    Abstract Women with epithelial ovarian cancer (EOC) are usually treated with platinum/taxane therapy after cytoreductive surgery but there is considerable inter-individual variation in response. To identify germline single-nucleotide polymorphisms (SNPs) that contribute to variations in individual responses to chemotherapy, we carried out a multi-phase genome-wide association study (GWAS) in 1,244 women diagnosed with serous EOC who were treated with the same first-line chemotherapy, carboplatin and paclitaxel. We identified two SNPs (rs7874043 and rs72700653) in TTC39B (best P=7x10-5, HR=1.90, for rs7874043) associated with progression-free survival (PFS). Functional analyses show that both SNPs lie in a putative regulatory element (PRE) that physically interacts with the promoters of PSIP1, CCDC171 and an alternative promoter of TTC39B. The C allele of rs7874043 is associated with poor PFS and showed increased binding of the Sp1 transcription factor, which is critical for chromatin interactions with PSIP1. Silencing of PSIP1 significantly impaired DNA damage-induced Rad51 nuclear foci and reduced cell viability in ovarian cancer lines. PSIP1 (PC4 and SFRS1 Interacting Protein 1) is known to protect cells from stress-induced apoptosis, and high expression is associated with poor PFS in EOC patients. We therefore suggest that the minor allele of rs7874043 confers poor PFS by increasing PSIP1 expression.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Chromatin Immunoprecipitation ; Cohort Studies ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/genetics ; Cystadenocarcinoma, Serous/mortality ; Cystadenocarcinoma, Serous/pathology ; Electrophoretic Mobility Shift Assay ; Enhancer Elements, Genetic/genetics ; Fallopian Tube Neoplasms/drug therapy ; Fallopian Tube Neoplasms/genetics ; Fallopian Tube Neoplasms/mortality ; Fallopian Tube Neoplasms/pathology ; Female ; Follow-Up Studies ; Germ-Line Mutation/genetics ; Humans ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Peritoneal Neoplasms/drug therapy ; Peritoneal Neoplasms/genetics ; Peritoneal Neoplasms/mortality ; Peritoneal Neoplasms/pathology ; Polymorphism, Single Nucleotide/genetics ; Prognosis ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Survival Rate ; Transcription Factors/genetics ; Tumor Cells, Cultured
    Chemical Substances Adaptor Proteins, Signal Transducing ; Biomarkers, Tumor ; PSIP1 protein, human ; RNA, Messenger ; Transcription Factors
    Language English
    Publishing date 2016-02-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.7047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

    Kelemen, Linda E / Earp, Madalene / Fridley, Brooke L / Chenevix-Trench, Georgia / Fasching, Peter A / Beckmann, Matthias W / Ekici, Arif B / Hein, Alexander / Lambrechts, Diether / Lambrechts, Sandrina / Van Nieuwenhuysen, Els / Vergote, Ignace / Rossing, Mary Anne / Doherty, Jennifer A / Chang-Claude, Jenny / Behrens, Sabine / Moysich, Kirsten B / Cannioto, Rikki / Lele, Shashikant /
    Odunsi, Kunle / Goodman, Marc T / Shvetsov, Yurii B / Thompson, Pamela J / Wilkens, Lynne R / Dörk, Thilo / Antonenkova, Natalia / Bogdanova, Natalia / Hillemanns, Peter / Runnebaum, Ingo B / du Bois, Andreas / Harter, Philipp / Heitz, Florian / Schwaab, Ira / Butzow, Ralf / Pelttari, Liisa M / Nevanlinna, Heli / Modugno, Francesmary / Edwards, Robert P / Kelley, Joseph L / Ness, Roberta B / Karlan, Beth Y / Lester, Jenny / Orsulic, Sandra / Walsh, Christine / Kjaer, Susanne K / Jensen, Allan / Cunningham, Julie M / Vierkant, Robert A / Giles, Graham G / Bruinsma, Fiona / Southey, Melissa C / Hildebrandt, Michelle A T / Liang, Dong / Lu, Karen / Wu, Xifeng / Sellers, Thomas A / Levine, Douglas A / Schildkraut, Joellen M / Iversen, Edwin S / Terry, Kathryn L / Cramer, Daniel W / Tworoger, Shelley S / Poole, Elizabeth M / Bandera, Elisa V / Olson, Sara H / Orlow, Irene / Vestrheim Thomsen, Liv Cecilie / Bjorge, Line / Krakstad, Camilla / Tangen, Ingvild L / Kiemeney, Lambertus A / Aben, Katja K H / Massuger, Leon F A G / van Altena, Anne M / Pejovic, Tanja / Bean, Yukie / Kellar, Melissa / Cook, Linda S / Le, Nhu D / Brooks-Wilson, Angela / Gronwald, Jacek / Cybulski, Cezary / Jakubowska, Anna / Lubiński, Jan / Wentzensen, Nicolas / Brinton, Louise A / Lissowska, Jolanta / Hogdall, Estrid / Engelholm, Svend Aage / Hogdall, Claus / Lundvall, Lene / Nedergaard, Lotte / Pharoah, Paul D P / Dicks, Ed / Song, Honglin / Tyrer, Jonathan P / McNeish, Iain / Siddiqui, Nadeem / Carty, Karen / Glasspool, Rosalind / Paul, James / Campbell, Ian G / Eccles, Diana / Whittemore, Alice S / McGuire, Valerie / Rothstein, Joseph H / Sieh, Weiva / Narod, Steven A / Phelan, Catherine M / McLaughlin, John R / Risch, Harvey A / Anton-Culver, Hoda / Ziogas, Argyrios / Menon, Usha / Gayther, Simon A / Gentry-Maharaj, Aleksandra / Ramus, Susan J / Wu, Anna H / Pearce, Celeste Leigh / Lee, Alice W / Pike, Malcolm C / Kupryjanczyk, Jolanta / Podgorska, Agnieszka / Plisiecka-Halasa, Joanna / Sawicki, Wlodzimierz / Goode, Ellen L / Berchuck, Andrew

    International journal of molecular sciences

    2018  Volume 19, Issue 9

    Abstract: Thymidylate synthase (TYMS) is a crucial enzyme for DNA synthesis. TYMS expression is regulated by its antisense mRNA, ENOSF1. Disrupted regulation may promote uncontrolled DNA synthesis and tumor growth. We sought to replicate our previously reported ... ...

    Abstract Thymidylate synthase (TYMS) is a crucial enzyme for DNA synthesis. TYMS expression is regulated by its antisense mRNA, ENOSF1. Disrupted regulation may promote uncontrolled DNA synthesis and tumor growth. We sought to replicate our previously reported association between rs495139 in the
    MeSH term(s) Adenocarcinoma, Mucinous/genetics ; Adenocarcinoma, Mucinous/metabolism ; Adenocarcinoma, Mucinous/pathology ; Case-Control Studies ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Association Studies ; Humans ; Hydro-Lyases ; Logistic Models ; Middle Aged ; Odds Ratio ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Proteins/genetics ; Proteins/metabolism ; Quantitative Trait Loci ; RNA, Antisense/genetics ; RNA, Antisense/metabolism ; Risk ; Signal Transduction ; Thymidylate Synthase/genetics ; Thymidylate Synthase/metabolism
    Chemical Substances Proteins ; RNA, Antisense ; TYMS protein, human (EC 2.1.1.45) ; Thymidylate Synthase (EC 2.1.1.45) ; ENOSF1 protein, human (EC 4.2.1.-) ; Hydro-Lyases (EC 4.2.1.-)
    Language English
    Publishing date 2018-08-21
    Publishing country Switzerland
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms19092473
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

    Dixon-Suen, Suzanne C / Nagle, Christina M / Thrift, Aaron P / Pharoah, Paul D P / Ewing, Ailith / Pearce, Celeste Leigh / Zheng, Wei / Chenevix-Trench, Georgia / Fasching, Peter A / Beckmann, Matthias W / Lambrechts, Diether / Vergote, Ignace / Lambrechts, Sandrina / Van Nieuwenhuysen, Els / Rossing, Mary Anne / Doherty, Jennifer A / Wicklund, Kristine G / Chang-Claude, Jenny / Jung, Audrey Y /
    Moysich, Kirsten B / Odunsi, Kunle / Goodman, Marc T / Wilkens, Lynne R / Thompson, Pamela J / Shvetsov, Yurii B / Dörk, Thilo / Park-Simon, Tjoung-Won / Hillemanns, Peter / Bogdanova, Natalia / Butzow, Ralf / Nevanlinna, Heli / Pelttari, Liisa M / Leminen, Arto / Modugno, Francesmary / Ness, Roberta B / Edwards, Robert P / Kelley, Joseph L / Heitz, Florian / du Bois, Andreas / Harter, Philipp / Schwaab, Ira / Karlan, Beth Y / Lester, Jenny / Orsulic, Sandra / Rimel, Bobbie J / Kjær, Susanne K / Høgdall, Estrid / Jensen, Allan / Goode, Ellen L / Fridley, Brooke L / Cunningham, Julie M / Winham, Stacey J / Giles, Graham G / Bruinsma, Fiona / Milne, Roger L / Southey, Melissa C / Hildebrandt, Michelle A T / Wu, Xifeng / Lu, Karen H / Liang, Dong / Levine, Douglas A / Bisogna, Maria / Schildkraut, Joellen M / Berchuck, Andrew / Cramer, Daniel W / Terry, Kathryn L / Bandera, Elisa V / Olson, Sara H / Salvesen, Helga B / Thomsen, Liv Cecilie Vestrheim / Kopperud, Reidun K / Bjorge, Line / Kiemeney, Lambertus A / Massuger, Leon F A G / Pejovic, Tanja / Bruegl, Amanda / Cook, Linda S / Le, Nhu D / Swenerton, Kenneth D / Brooks-Wilson, Angela / Kelemen, Linda E / Lubiński, Jan / Huzarski, Tomasz / Gronwald, Jacek / Menkiszak, Janusz / Wentzensen, Nicolas / Brinton, Louise / Yang, Hannah / Lissowska, Jolanta / Høgdall, Claus K / Lundvall, Lene / Song, Honglin / Tyrer, Jonathan P / Campbell, Ian / Eccles, Diana / Paul, James / Glasspool, Rosalind / Siddiqui, Nadeem / Whittemore, Alice S / Sieh, Weiva / McGuire, Valerie / Rothstein, Joseph H / Narod, Steven A / Phelan, Catherine / Risch, Harvey A / McLaughlin, John R / Anton-Culver, Hoda / Ziogas, Argyrios / Menon, Usha / Gayther, Simon A / Ramus, Susan J / Gentry-Maharaj, Aleksandra / Wu, Anna H / Pike, Malcolm C / Tseng, Chiu-Chen / Kupryjanczyk, Jolanta / Dansonka-Mieszkowska, Agnieszka / Budzilowska, Agnieszka / Rzepecka, Iwona K / Webb, Penelope M

    British journal of cancer

    2018  Volume 118, Issue 8, Page(s) 1123–1129

    Abstract: Background: Observational studies suggest greater height is associated with increased ovarian cancer risk, but cannot exclude bias and/or confounding as explanations for this. Mendelian randomisation (MR) can provide evidence which may be less prone to ... ...

    Abstract Background: Observational studies suggest greater height is associated with increased ovarian cancer risk, but cannot exclude bias and/or confounding as explanations for this. Mendelian randomisation (MR) can provide evidence which may be less prone to bias.
    Methods: We pooled data from 39 Ovarian Cancer Association Consortium studies (16,395 cases; 23,003 controls). We applied two-stage predictor-substitution MR, using a weighted genetic risk score combining 609 single-nucleotide polymorphisms. Study-specific odds ratios (OR) and 95% confidence intervals (CI) for the association between genetically predicted height and risk were pooled using random-effects meta-analysis.
    Results: Greater genetically predicted height was associated with increased ovarian cancer risk overall (pooled-OR (pOR) = 1.06; 95% CI: 1.01-1.11 per 5 cm increase in height), and separately for invasive (pOR = 1.06; 95% CI: 1.01-1.11) and borderline (pOR = 1.15; 95% CI: 1.02-1.29) tumours.
    Conclusions: Women with a genetic propensity to being taller have increased risk of ovarian cancer. This suggests genes influencing height are involved in pathways promoting ovarian carcinogenesis.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Body Height/genetics ; Body Height/physiology ; Carcinoma, Ovarian Epithelial/epidemiology ; Carcinoma, Ovarian Epithelial/genetics ; Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Geography ; Humans ; Mendelian Randomization Analysis ; Middle Aged ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/genetics ; Risk Factors ; Young Adult
    Language English
    Publishing date 2018-03-20
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 80075-2
    ISSN 1532-1827 ; 0007-0920
    ISSN (online) 1532-1827
    ISSN 0007-0920
    DOI 10.1038/s41416-018-0011-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.

    Block, Matthew S / Charbonneau, Bridget / Vierkant, Robert A / Fogarty, Zachary / Bamlet, William R / Pharoah, Paul D P / Rossing, Mary Anne / Cramer, Daniel / Pearce, Celeste Leigh / Schildkraut, Joellen / Menon, Usha / Kjaer, Susanne K / Levine, Douglas A / Gronwald, Jacek / Culver, Hoda Anton / Whittemore, Alice S / Karlan, Beth Y / Lambrechts, Diether / Wentzensen, Nicolas /
    Kupryjanczyk, Jolanta / Chang-Claude, Jenny / Bandera, Elisa V / Hogdall, Estrid / Heitz, Florian / Kaye, Stanley B / Fasching, Peter A / Campbell, Ian / Goodman, Marc T / Pejovic, Tanja / Bean, Yukie T / Hays, Laura E / Lurie, Galina / Eccles, Diana / Hein, Alexander / Beckmann, Matthias W / Ekici, Arif B / Paul, James / Brown, Robert / Flanagan, James M / Harter, Philipp / du Bois, Andreas / Schwaab, Ira / Hogdall, Claus K / Lundvall, Lene / Olson, Sara H / Orlow, Irene / Paddock, Lisa E / Rudolph, Anja / Eilber, Ursula / Dansonka-Mieszkowska, Agnieszka / Rzepecka, Iwona K / Ziolkowska-Seta, Izabela / Brinton, Louise A / Yang, Hannah / Garcia-Closas, Montserrat / Despierre, Evelyn / Lambrechts, Sandrina / Vergote, Ignace / Walsh, Christine S / Lester, Jenny / Sieh, Weiva / McGuire, Valerie / Rothstein, Joseph H / Ziogas, Argyrios / Lubiński, Jan / Cybulski, Cezary / Menkiszak, Janusz / Jensen, Allan / Gayther, Simon A / Ramus, Susan J / Gentry-Maharaj, Aleksandra / Berchuck, Andrew / Wu, Anna H / Pike, Malcolm C / Van Den Berg, David / Terry, Kathryn L / Vitonis, Allison F / Ramirez, Starr M / Rider, David N / Knutson, Keith L / Sellers, Thomas A / Phelan, Catherine M / Doherty, Jennifer A / Johnatty, Sharon E / deFazio, Anna / Song, Honglin / Tyrer, Jonathan / Kalli, Kimberly R / Fridley, Brooke L / Cunningham, Julie M / Goode, Ellen L

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

    2014  Volume 23, Issue 7, Page(s) 1421–1427

    Abstract: Survival in epithelial ovarian cancer (EOC) is influenced by the host immune response, yet the key genetic determinants of inflammation and immunity that affect prognosis are not known. The nuclear factor-κB (NF-κB) transcription factor family plays an ... ...

    Abstract Survival in epithelial ovarian cancer (EOC) is influenced by the host immune response, yet the key genetic determinants of inflammation and immunity that affect prognosis are not known. The nuclear factor-κB (NF-κB) transcription factor family plays an important role in many immune and inflammatory responses, including the response to cancer. We studied common inherited variation in 210 genes in the NF-κB family in 10,084 patients with invasive EOC (5,248 high-grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous) from the Ovarian Cancer Association Consortium. Associations between genotype and overall survival were assessed using Cox regression for all patients and by major histology, adjusting for known prognostic factors and correcting for multiple testing (threshold for statistical significance, P < 2.5 × 10(-5)). Results were statistically significant when assessed for patients of a single histology. Key associations were with caspase recruitment domain family, member 11 (CARD11) rs41324349 in patients with mucinous EOC [HR, 1.82; 95% confidence interval (CI), 1.41-2.35; P = 4.13 × 10(-6)] and tumor necrosis factor receptor superfamily, member 13B (TNFRSF13B) rs7501462 in patients with endometrioid EOC (HR, 0.68; 95% CI, 0.56-0.82; P = 2.33 × 10(-5)). Other associations of note included TNF receptor-associated factor 2 (TRAF2) rs17250239 in patients with high-grade serous EOC (HR, 0.84; 95% CI, 0.77-0.92; P = 6.49 × 10(-5)) and phospholipase C, gamma 1 (PLCG1) rs11696662 in patients with clear cell EOC (HR, 0.43; 95% CI, 0.26-0.73; P = 4.56 × 10(-4)). These associations highlight the potential importance of genes associated with host inflammation and immunity in modulating clinical outcomes in distinct EOC histologies.
    MeSH term(s) Adult ; Aged ; Carcinoma, Ovarian Epithelial ; Female ; Genotype ; Humans ; Middle Aged ; NF-kappa B/genetics ; Neoplasm Invasiveness ; Neoplasms, Glandular and Epithelial/genetics ; Neoplasms, Glandular and Epithelial/mortality ; Neoplasms, Glandular and Epithelial/pathology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Proportional Hazards Models ; Signal Transduction/genetics
    Chemical Substances NF-kappa B
    Language English
    Publishing date 2014-04-16
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1153420-5
    ISSN 1538-7755 ; 1055-9965
    ISSN (online) 1538-7755
    ISSN 1055-9965
    DOI 10.1158/1055-9965.EPI-13-0962
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top